Brief: Control Bionics Announces First U.S. Letter Of Intent For Ios Speech Device Program
26/03/2026 24:59
March 26 (Reuters) - Control Bionics Ltd CBL.AX: FIRST U.S. LETTER OF INTENT FOR IOS SPEECH DEVICE PROGRAM U.S. LETTER OF INTENT FOR IOS SPEECH DEVICE PROGRAM SHIPMENTS UNDER PROGRAM ARE EXPECTED TO COMMENCE TOWARDS END OF FY26 LOI OUTLINES CUSTOMER'S INTENTION TO BUY SIGNIFICANT NUMBER OF IOS- BASED SPEECH GENERATING DEVICES ANNUALLY DEVICE VOLUME ONCE DELIVERED IS EXPECTED TO GENERATE BETWEEN US$2.5-3.5M REVENUE ANNUALLY Further company coverage: CBL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device